Company facts
Early-stage
- Founded
- 2022
- Employees
- 3
- Headquarters
- United States
About
TYBR is developing a hydrogel to limit internal scarring after surgery. The naturally derived material is applied to coat tendons at the end of surgery to improve healing outcomes for the millions Americans who undergo tendon or ligament surgery each year.